The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.
about
From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentHow the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.Antidepressant response and the serotonin transporter gene-linked polymorphic regionPharmacogenetics of antidepressant response.Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy.Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adultsPersonalized medicine in psychiatry: problems and promises.Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.Pharmacogenetics of antidepressantsPharmacogenetics in drug regulation: promise, potential and pitfalls.SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.The promise and reality of pharmacogenetics in psychiatryPharmacogenomic strategy for individualizing antidepressant therapy.Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.Brain SERT Expression of Male Rats Is Reduced by Aging and Increased by Testosterone RestitutionAssociation of Anxiety Symptoms in Offspring of Bipolar Parents with Serotonin Transporter-Linked Polymorphic Region (5-HTTLPR) Genotype.Emerging strategies and applications of pharmacogenomicsSerotonin transporters: implications for antidepressant drug development.Pharmacogenomics and antidepressant drugs.Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patientsSertraline for the treatment of depression in Alzheimer disease: genetic influences.Living well with stroke: design and methods for a randomized controlled trial of a psychosocial behavioral intervention for poststroke depressionSerotonergic vulnerability and depression: assumptions, experimental evidence and implications.Pharmacogenetic studies in depression: a proposal for methodologic guidelines.The serotonin transporter gene and effectiveness of SSRIs.Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder.Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models.Systematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatmentSerotonin Transporter Polymorphism (5-HTTLPR) and Citalopram Effectiveness in Iranian Patients with Major Depressive Disorder.Clinical implications of genetic variation in the serotonin transporter promoter region: a review.Pharmacogenetics of antidepressant response: an updateRole of pharmacogenomics in drug discovery and development.Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.Personalized medicine for depression: can we match patients with treatments?Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.CB1 receptor antagonists: new discoveries leading to new perspectives.
P2860
Q27015830-EE683CFF-8C2D-422F-A5AC-82054BD79E76Q30485725-878BB1F5-1BB3-460B-AE4F-18FC3E902175Q33921338-EE005697-09C1-423D-A297-365B6E9D167BQ34088515-A5FDE3ED-1D38-48F4-8219-555A4A9DD82CQ34155796-34D03158-C7F6-4200-9E91-5DEFB72BACA9Q34316695-BCF34099-8388-4C9B-842D-049D94D7A853Q34424865-3F82C44C-7EF8-49C2-A4A9-E4225710AC7EQ34473840-F8711534-5D91-4768-93D0-A03F71F87883Q34685706-9B9BAB09-4FDC-45CB-8CCE-C4B7E4C171AEQ34726454-C451B5D1-38FC-4909-8B18-1EAFD1F9FDDDQ34871885-67317016-4519-4362-95CF-59930EF54991Q35026088-26AF518E-7140-4C7F-AFEC-92CEB9A37C2CQ35038052-74185E3F-C27D-4DA4-930A-149BDAB8FDA8Q35174393-6F6EA4C7-6AD0-40AF-B29E-0DCF8C5CF98AQ35226451-2B5C49D8-CBCD-48FB-A2B2-BA7A799B4D84Q35237038-92E88CA7-A10C-4CCD-9F6E-C6D30F28A528Q35237042-7DD233BC-7CB9-4AE2-8E64-B483E57E8612Q35623234-87567712-DEDB-40B2-AE13-8A1A7910D5DDQ35984750-43B664E1-D8DB-4BEE-9633-DA03DDDB5A89Q35988130-1B5DFB77-D9DF-435E-AC52-06CC529C0433Q36341615-BBFBC5C2-9830-4B3E-BA2F-B3D5A48EFF4DQ36438205-E3FB39C7-8C85-43DD-8E12-E8ABC133E846Q36491587-18BC4533-B4B2-4D03-9ECD-F4B092596F86Q36503660-1B1D5A09-0A29-4A33-BFC5-2037F400BD1CQ36675827-D8AB90AF-3C5D-4456-9DF9-FACE4169127FQ36679249-48A4D8F3-B459-470C-ACC5-83ABD95CC31FQ36904466-882E77C8-C50A-4942-B889-E06F843BC934Q37035245-69C2957B-F2C8-4CF4-944F-0C6ADB3CAA9AQ37147173-2C5639FA-75B4-4EEA-8EBB-5C5333265D85Q37200660-CB0D862E-12E2-4589-9432-483F822AEBC4Q37217494-C92256BC-D77A-46E1-A3F4-0C1A30281D96Q37229060-AB5FB855-FF4B-4175-9A79-3EB88FCB6C62Q37255370-ECEB4820-BC23-4D3F-8BBB-0C63C17DCD48Q37464458-4382F7F7-88DC-45D4-8F3C-F616A6A1D85BQ37472933-9CB0BB7E-42D1-4ADE-AB06-F3EB917FBFE4Q37514278-BEA61C54-DE12-482F-9D65-A042DF867DC9Q37789098-E3237CFC-BF6D-4637-A3A3-2B92D7CD62BCQ37791156-CEB7BCB5-600B-4531-BE65-6893E0366911Q37989490-9159472D-45D7-4DE8-83C7-BBCEA3FAEDE4Q37998561-7B0DFC7D-A59E-4C4F-AE8B-E78B7C9E7DDE
P2860
The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The serotonin transporter poly ...... ith major depressive disorder.
@ast
The serotonin transporter poly ...... ith major depressive disorder.
@en
The serotonin transporter poly ...... ith major depressive disorder.
@nl
type
label
The serotonin transporter poly ...... ith major depressive disorder.
@ast
The serotonin transporter poly ...... ith major depressive disorder.
@en
The serotonin transporter poly ...... ith major depressive disorder.
@nl
prefLabel
The serotonin transporter poly ...... ith major depressive disorder.
@ast
The serotonin transporter poly ...... ith major depressive disorder.
@en
The serotonin transporter poly ...... ith major depressive disorder.
@nl
P2093
P1433
P1476
The serotonin transporter poly ...... ith major depressive disorder.
@en
P2093
Albert B Seymour
Cathryn M Clary
L Kathryn Durham
Patrice M Milos
Suzin M Webb
P2888
P304
P356
10.1007/S00213-003-1562-3
P577
2003-09-04T00:00:00Z
P6179
1023809325